Filippi, L.; Bagni, O.; Crisafulli, C.; Cerio, I.; Brunotti, G.; Chiaravalloti, A.; Schillaci, O.; Dore, F.
Detection Rate and Clinical Impact of PET/CT with 18F-FACBC in Patients with Biochemical Recurrence of Prostate Cancer: A Retrospective Bicentric Study. Biomedicines 2022, 10, 177.
https://doi.org/10.3390/biomedicines10010177
AMA Style
Filippi L, Bagni O, Crisafulli C, Cerio I, Brunotti G, Chiaravalloti A, Schillaci O, Dore F.
Detection Rate and Clinical Impact of PET/CT with 18F-FACBC in Patients with Biochemical Recurrence of Prostate Cancer: A Retrospective Bicentric Study. Biomedicines. 2022; 10(1):177.
https://doi.org/10.3390/biomedicines10010177
Chicago/Turabian Style
Filippi, Luca, Oreste Bagni, Carmelo Crisafulli, Ivan Cerio, Gabriele Brunotti, Agostino Chiaravalloti, Orazio Schillaci, and Franca Dore.
2022. "Detection Rate and Clinical Impact of PET/CT with 18F-FACBC in Patients with Biochemical Recurrence of Prostate Cancer: A Retrospective Bicentric Study" Biomedicines 10, no. 1: 177.
https://doi.org/10.3390/biomedicines10010177
APA Style
Filippi, L., Bagni, O., Crisafulli, C., Cerio, I., Brunotti, G., Chiaravalloti, A., Schillaci, O., & Dore, F.
(2022). Detection Rate and Clinical Impact of PET/CT with 18F-FACBC in Patients with Biochemical Recurrence of Prostate Cancer: A Retrospective Bicentric Study. Biomedicines, 10(1), 177.
https://doi.org/10.3390/biomedicines10010177